A new Food and Drug Administration analysis backs earlier suggestions of a link between at least some antidepressants used by children and suicidal tendencies, prompting the agency to prepare new warnings.Exactly what those warnings will say, and which drugs will be affected, hasn’t been settled, according to FDA documents released Friday. The agency will take the debate to its scientific advisers next month for help in deciding.
